RUVOLETTO, MARIAGRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.472
AS - Asia 474
EU - Europa 410
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.358
Nazione #
US - Stati Uniti d'America 2.471
CN - Cina 276
SG - Singapore 153
IT - Italia 117
SE - Svezia 85
FI - Finlandia 81
DE - Germania 54
IN - India 21
FR - Francia 19
GB - Regno Unito 19
VN - Vietnam 16
UA - Ucraina 15
IE - Irlanda 14
NL - Olanda 4
HK - Hong Kong 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CA - Canada 1
EU - Europa 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
PH - Filippine 1
PK - Pakistan 1
Totale 3.358
Città #
Chandler 303
Fairfield 299
Woodbridge 197
Jacksonville 156
Wilmington 136
Ann Arbor 132
Houston 128
Ashburn 121
Singapore 121
Santa Clara 106
Seattle 95
Boardman 92
Cambridge 90
Padova 67
Nanjing 50
Princeton 50
Des Moines 45
Helsinki 43
Beijing 42
Medford 39
San Diego 32
Roxbury 27
Dearborn 24
Dong Ket 15
Hefei 15
Shenyang 15
Dublin 14
New York 14
Jinan 11
Pune 11
Changsha 10
Guangzhou 9
Nanchang 8
Shanghai 8
Hebei 7
Kunming 7
Norwalk 7
Tianjin 6
Jiaxing 5
Springfield 5
Zhengzhou 5
Dallas 4
Frankfurt am Main 4
London 4
Ningbo 4
Pesaro 4
Haikou 3
Los Angeles 3
Ogden 3
Paris 3
Prineville 3
Turin 3
Brescia 2
Campodarsego 2
Columbus 2
Florence 2
Hong Kong 2
Hounslow 2
Mestre 2
Milan 2
Phoenix 2
Redwood City 2
Riese Pio X 2
Rockville 2
Rome 2
Tappahannock 2
Trento 2
Urbino 2
Vico del Gargano 2
Almaty 1
Amman 1
Amsterdam 1
Arezzo 1
Atlanta 1
Baku 1
Baotou 1
Chongqing 1
Everett 1
Falkenstein 1
Forest City 1
Genoa 1
Guiyang 1
Hangzhou 1
Harbin 1
Ho Chi Minh City 1
Iligan City 1
Indiana 1
Islamabad 1
Jinhua 1
Kharkiv 1
Lanzhou 1
Lappeenranta 1
Las Vegas 1
Limbiate 1
Munich 1
Nanning 1
Newark 1
Novara 1
Piove Di Sacco 1
Portsmouth 1
Totale 2.670
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 189
SERPINB3 induces epithelial-mesenchymal transition. 127
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 120
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 115
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 112
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 108
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 107
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 99
Hepatic progenitor cells express SerpinB3 97
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 95
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 94
SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. 91
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 85
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 83
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 77
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 75
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 74
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 73
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 73
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 72
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 67
Does HCV infection have a more favourable outcome in Tanzanian people? Data from the Lugalawa study 63
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 63
SERPINB3 modulates TGF-beta expression in chronic liver disease. 61
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 60
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 59
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 59
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 58
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 58
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 54
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 51
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 51
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 51
Engineered EVs for oxidative stress protection 51
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 48
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 47
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 45
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 43
DETERMINAZIONE DELL’IMMUNOCOMPLESSO VEGF-IgM NELL’ EPATOCARCINOMA 43
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 42
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 39
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 36
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 35
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 34
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 33
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 33
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 30
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 16
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 15
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 14
SerpinB3 administration protects liver against ischemia-reperfusion injury 12
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 12
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 11
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 11
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 8
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 6
Totale 3.385
Categoria #
all - tutte 13.453
article - articoli 10.470
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 160
selected - selezionate 0
volume - volumi 0
Totale 24.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020467 0 0 0 0 43 50 99 71 51 87 33 33
2020/2021430 12 19 9 13 12 46 10 21 67 79 56 86
2021/2022475 10 87 56 35 12 32 20 41 12 7 57 106
2022/2023594 92 63 21 66 100 99 0 51 72 3 20 7
2023/2024327 6 59 46 26 35 45 21 12 4 13 29 31
2024/2025445 8 162 55 75 145 0 0 0 0 0 0 0
Totale 3.385